Evidence map›Paper›PMID 40627924›Full record

SynthesisSleep medicine reviews2025

Estimation of the global prevalence and burden of insomnia: a systematic literature review-based analysis.

Adam V Benjafield, Fatima H Sert Kuniyoshi, Atul Malhotra, Jennifer L Martin, Charles M Morin, Leonie F Maurer, Peter A Cistulli, Jean-Louis Pépin, Emerson M Wickwire, medXcloud group

Abstract readSystematic Review
In one paragraph

Synthesis in Sleep medicine reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 12 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 12 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Psychometric evaluation of the Pittsburgh Sleep Quality Index among South African women participating in the Bukhali trial: Healthy Life Trajectories Initiative.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026
    Trial
  15. Trial
  16. Trial
  17. Trial
  18. Article
  19. Article
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adam V BenjafieldResMed Science Center, Sydney, NSW, Australia.
Fatima H Sert KuniyoshiResMed Science Center, San Diego, CA, USA.
Atul MalhotraUniversity California San Diego, La Jolla, CA, USA.
Jennifer L MartinGeriatric Research, Education and Clinical Center, VA Greater Los Angeles, Los Angeles, CA, USA; David Geffen School of Medicine, University of California, Los Angeles, Canada.
Charles M MorinUniversité Laval, Québec City, Canada.
Leonie F MaurerMementor DE GmbH, Leipzig, Germany.
Peter A CistulliCharles Perkins Centre, Faculty of Medicine and Health, University Sydney, and Department of Respiratory and Sleep Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.
Jean-Louis PépinHP2 Laboratory, Inserm U1300, Grenoble Alps University, Grenoble, France.
Emerson M WickwireUniversity of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: ewickwire@som.umaryland.edu.
medXcloud group

Funding

Is Obstructive Sleep Apnea Important in the Development of Alzheimer's DiseaseR01AG063925 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MALHOTRA, ATUL · 2020 to 2024
$3.7M
Underlying mechanisms of obesity-induced obstructive sleep apneaR01HL148436 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Atul Malhotra · 2020 to 2026
$3.4M
Sleep Apnea Endophenotypes: One Size Does Not Fit AllR01HL154926 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MALHOTRA, ATUL · 2021 to 2025
$3.3M
The cardiovascular consequences of sleep apnea plus COPD (Overlap syndrome)R01HL166485 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Atul Malhotra · 2023 to 2026
$3.1M
VentNet: A Real-Time Multimodal Data Integration Model for Prediction of Respiratory Failure in Patients with COVID-19R01HL157985 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MALHOTRA, ATUL, NEMATI, SHAMIM · 2022 to 2025
$2.9M
Developing a Diverse Next Generation of Leaders in Respiratory ScienceT32HL166127 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Laura Elise Crotty Alexander, Atul Malhotra · 2023 to 2026
$1.6M
HSRD VA IK6 HX003160NHLBI NIH HHS R01 HL148436NHLBI NIH HHS R01 HL154926NHLBI NIH HHS R01 HL157985NHLBI NIH HHS R01 HL166485NHLBI NIH HHS T32 HL166127NIA NIH HHS R01 AG063925
6 · The paper itself

Abstract

Insomnia is common, is associated with major adverse medical and mental health outcomes, has a negative impact on quality of life, and has significant economic consequences. However, little is known about the global insomnia burden. This systematic review estimated the global prevalence of insomnia in adults. PubMed and Embase were searched (terms "insomnia," "prevalence," and "general population") to identify relevant peer-reviewed studies (final search 2-3 Sep 2024). Included studies had the highest data quality and lowest risk of bias, and reported clinically relevant insomnia prevalence in the general population. Insomnia prevalence estimates were applied to United Nations (UN) population data using a country-specific study (if available) or the highest-quality study (if no country-specific study). Of 1651 potential records, 18 studies (262,582 participants) were included. Thirty-one of 237 UN/World Bank-recognized countries/territories had a suitable nation-specific adult insomnia prevalence estimate. 852,325,091 adults (95 % confidence interval 830,354,161-874,309,252) were estimated to have insomnia (global prevalence: 16.2 %) and 414,967,941 were estimated to have severe insomnia (7.9 %). Insomnia and severe insomnia were more prevalent in females versus males across all age groups. The high global prevalence of insomnia disorder reinforces the need for comprehensive public health and clinical sleep health initiatives worldwide. REGISTRATION: PROSPERO: CRD42024581410.

Indexed as

Cost of IllnessGlobal HealthSleep Initiation and Maintenance DisordersAdultHumansPrevalenceGlobalInsomniaPrevalenceSleep

Identifiers

PMID40627924
PMCPMC12676268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.